Figure 2.

Comparison of the clinical response rate and remission rate by disease distribution between the mono-AFM and A-FMT groups during short-term evaluation. Although no significant difference was observed in the mono-AFM (triple antibiotic therapy (amoxicillin, fosfomycin, and metronidazole)) group, the response and remission rates were significantly higher in patients with proctitis than in those with left-sided and extensive colitis in the A-FMT (fresh fecal microbiota transplantation (FMT) following triple antibiotic therapy (amoxicillin, fosfomycin, and metronidazole)) group (left-sided and extensive colitis, n = 46; proctitis, n = 9; clinical response, p = 0.06; clinical remission, p = 0.005, chi-square test).